Glucosese Metabolic Alteration and Related Disorders

Medical Advocates
HIV Infection/Disease

Glucose Metabolic Alterations/
Disorders

General Reports
Glucose Metabolism
Glucose Intolerance
Hyperinsulinemia
Hyperglycemia
Insulin Resistance/Dysregulation
Diabetes Mellitus

HIV Metabolic Disorders Main Page

Main New/Newsworthy

Home Page

Last Update: November 18, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

Journal Papers, Abstracts, and Commentaries

A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients
Initiating Combination Antiretroviral Therapy.
Walmsley S, Cheung AM, Fantus G, et al
HIV Clin Trials. 2008 Sep-Oct;9(5):314-23.
Abstract

Glucose Metabolism

Journal Papers, Abstracts, and Commentaries

HIV and HIV treatment: effects on fats, glucose and lipids.
Gkrania-Klotsas E, Klotsas AE.
Br Med Bull. 2007 Nov 2
Abstract

Disorders of glucose metabolism among HIV-infected women.
Howard AA, Floris-Moore M, Arnsten JH, et al
Clin Infect Dis. 2005 May 15;40(10):1492-9.
Abstract

Conference Reports, Abstracts, and Posters

Long-term changes in lipids and glucose/insulin levels among HIV-infected antiretroviral naïve
persons randomized to PI vs. NNRTI vs. PI + NNRTI-based antiretroviral regimens: results of
the CPCRA 061 metabolic study
Shlay J., Bartsch G., Peng G., et al
(XVI International AIDS Conference)
Abstract

Prospective Study of Glucose Metabolism in Antiretroviral Naïve HIV-Infected Patients:
Incidence of Insulin Resistance at 48 Weeks of HAART
R. PALACIOS, N. MERCHANTE, J. MACÍAS, et al
(45 ICAAC)
Abstract

Disorders of Glucose Metabolism and Insulin Resistance in HIV-infected
Patients Treated with Protease Inhibitors. Considerations on Frequency and
Clinical Management, in a Prospective Randomized Study
L Calza, RManfredi, F Chiodo
(12 CROI)
Abstract

Glucose Intolerance

Journal Papers, Abstracts, and Commentaries

Clinical lipoatrophy in HIV-1 patients on HAART is not associated with
increased abdominal girth, hyperlipidaemia or glucose intolerance.
Worm D, Kirk O, Andersen O, et al.
HIV Med 2002 Oct;3(4):239-46
Abstract

Hyperglycemia

Journal Papers, Abstracts, and Commentaries

Hyperinsulinemia

Journal Papers, Abstracts, and Commentaries

Hyperinsulinemia induced by highly active antiretroviral therapy in an
adolescent with polycystic ovary syndrome who was infected with human
immunodeficiency virus.
Vigano A, Manzoni P, Riva S, et al.
Fertil Steril 2003 Feb;79(2):422-3
Abstract

Hyperinsulinemic hypoglycemia associated with possible hypopituitarism in
a patient with acquired immunodeficiency syndrome.
Kim J, Mooradian AD.
Endocr Pract 2000 Nov-Dec;6(6):453-5
Abstract

FULL-TEXT ARTICLE
Fasting hyperinsulinemia in human immunodeficiency virus-infected men:
relationship to body composition, gonadal function, and protease inhibitor
use.
Hadigan C, Corcoran C, Stanley T, et al.
J Clin Endocrinol Metab 2000 Jan;85(1):35-41
Paper

Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting
individuals with AIDS.
Shikuma CM, Waslien C, McKeague J, et al.
AIDS 1999 Jul 30;13(11):1359-65
Abstract

Conference Reports, Abstracts, and Posters

Effects of Metformin and Rosiglitazone on Body Composition in HIV-infected Patients with
Hyperinsulinemia and Elevated Waist/Hip Ratio: A Randomized, Placebo-controlled Trial
K Mulligan, Y Yang, S Koletar, et al
(13 CROI)
Abstract

Dyslipemia and Hyperinsulinemia in HIV Patients on HAART
FRANCISCO A. GOMEZ, S. P. ROMERO, et al
(41 ICAAC)
Abstract

Insulin Resistance/Dysregulation

Journal Papers, Abstracts, and Commentaries

Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection.
Samaras K, Gan SK, Peake PW,
Obesity (Silver Spring). 2008 Nov 13.
Abstract

Antiretroviral Therapy Exposure and Insulin Resistance in the Women's Interagency HIV Study.
Tien PC, Schneider MF, Cole SR, et al
J Acquir Immune Defic Syndr. 2008 Oct 16
Abstract

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients:
pathogenesis, prevention, and treatment options.
Tebas P
J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S86-92.
Abstract

Insulin Resistance in HIV Infection: Drugs, Host Responses, or Restoration to Health?
Grunfeld C
Top HIV Med. 2008 Jun-Jul;16(2):89-93.
Abstract

Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.
He Q, Engelson ES, Ionescu G,et al
Antivir Ther. 2008;13(3):423-8.
Abstract

FULL TEXT ARTICLE
Effect of rosiglitazone and metformin on insulin resistance in patients infected with human
immunodeficiency virus receiving highly active antiretroviral therapy containing protease
inhibitor: randomized prospective controlled clinical trial.
Silic A, Janez A, Tomazic J, et al
Croat Med J. 2007 Dec;48(6):791-9.
Paper

Hepatitis C and insulin resistance: steatosis, fibrosis and non-response.
Romero-Gomez M.
Rev Esp Enferm Dig. 2006 Aug;98(8):605-615.
Abstract

Insulin Resistance in the HIV-Infected Population: The Potential Role of Mitochondrial
Dysfunction.
Shikuma CM, Day LJ, Gerschenson M.
Curr Drug Targets Infect Disord. 2005 Sep;5(3):255-62
Abstract

Insulin Resistance in HIV-Infected Men and Women in the Nutrition for Healthy Living Cohort.
Jones CY, Wilson IB, Greenberg AS
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):202-211.
Abstract

The Fatty liver and insulin resistance.
Yki-Jarvinen H, Westerbacka J.
Curr Mol Med. 2005 May;5(3):287-95
Abstract

Insulin resistance, HIV infection, and anti-HIV therapies.
Taiwo BO.
AIDS Read. 2005 Apr;15(4):171-6, 179-80
Abstract

Methods for quantifying insulin resistance in human immunodeficiency
virus-positive patients.
Chu JW, Abbasi F, Beatty GW
Metabolism. 2003 Jul;52(7):858-861.
Abstract

AIDS-related Insulin Resistance and Lipodystrophy Syndrome.
Kino T, Chrousos GP.
Curr Drug Targets Immune Endocr Metabol Disord 2003 Jun;3(2):111-7
Abstract

FULL-TEXT ARTICLE
Insulin and Carbohydrate Dysregulation
Gelato MC
Clinical Infectious Diseases 2003;36:S91-S95
Paper

Bezafibrate-induced improvement in glucose uptake and endothelial function
in protease inhibitor-associated insulin resistance.
Nystrom T, Bratt G, Sjoholm A.
J Intern Med 2002 Dec;252(6):570-4
Abstract

FULL-TEXT ARTICLE
Impaired glucose phosphorylation and transport in skeletal muscle cause
insulin resistance in HIV-1-infected patients with lipodystrophy.
Behrens GM, Boerner AR, Weber K, et al.
Clin Invest 2002 Nov 1;110(9):1319-1327
Abstract

The paradox of improved antiretroviral therapy in HIV: potential for nutritional
modulation?
Ware LJ, Wootton SA, Morlese JM, e al.
Proc Nutr Soc 2002 Feb;61(1):131-6
Abstract

Insulin resistance in the HIV-lipodystrophy syndrome.
Grinspoon S.
Trends Endocrinol Metab 2001Nov 1;12(9):413-9
Abstract

Selective aspects of the insulin resistance syndrome.
Corry DB, Tuck ML.
Curr Opin Nephrol Hypertens 2001 Jul;10(4):507-14
Abstract

Major insulin resistance syndromes: clinical and physiopathological aspects
Vigouroux C, Magre J, Desbois-Mouthon C, et al.
J Soc Biol 2001;195(3):249-57
Abstract

Conference Reports, Abstracts, and Posters

POSTER
Chromium Supplementation Decreases Insulin Resistance and Trunk Fat
E Aghdassi, I Salit, S Mohammed, et al
(15 CROI)
PDF Poster Abstract

POSTER
ART Exposure and Insulin Resistance in the Women’s Interagency HIV Study
P Tien, M Schneide, S Cole, et al
(15 CROI)
PDF Poster Abstract

Improvements in Hepatic and Adipocyte Insulin Sensitivity, Dyslipidemia, and Visceral Fat
during Leptin Treatment in HIV-infected Men with Lipoatrophy and Hypoleptinemia
K Mulligan, H Khatami, J M Schwarz, et al
(14 CROI)
Abstract

POSTER
Screening for Insulin Resistance in HIV Infection
J Falutz, R Gardiner
(9 CROI)
PDF Poster Abstract

Diabetes Mellitus

Journal Papers, Abstracts, and Commentaries

Incidence and risk factors for new onset diabetes mellitus in HIV infected patients:
the D:A:D study.
De Wit S, Sabin CA, Weber R, et al
Diabetes Care. 2008 Feb 11
Abstract

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of
antiretroviral therapy in HIV infection.
Wand H, Calmy A, Carey DL, Samaras K, et al
AIDS. 2007 Nov 30;21(18):2445-2453.
Abstract

Rosiglitazone increases small dense low-density lipoprotein concentration and decreases
high-density lipoprotein particle size in HIV-infected patients.
Hadigan C, Mazza S, Crum D, Grinspoon S.
AIDS. 2007 Nov 30;21(18):2543-2546.
Abstract

Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants
in the Swiss HIV Cohort Study.
Ledergerber B, Furrer H, Rickenbach M, et al
Clin Infect Dis. 2007 Jul 1;45(1):111-9.
Abstract

Achieving American Diabetes Association goals in HIV-seropositive patients with
diabetes mellitus.
Bury JE, Stroup JS, Stephens JR, Baker DL.
Proc (Bayl Univ Med Cent). 2007 Apr;20(2):118-123.
Abstract

A Comparison of Factors Associated With Prevalent Diabetes Mellitus Among HIV-Infected
Antiretroviral-Naive Individuals Versus Individuals in the National Health and Nutritional
Examination Survey Cohort.
Brar I, Shuter J, Thomas A, Daniels E, et al
J Acquir Immune Defic Syndr. 2007 Jan 22
Abstract

Apparent Resolution of Type 2 Diabetes Mellitus after Initiation of Potent Antiretroviral
Therapy in a Man from Africa with HIV Infection.
Koeppe J, Kosmiski L.
Clin Infect Dis. 2006 May 15;42(10):e79-81.
Abstract

Diabetes, Insulin Resistance, and HIV.
Hadigan C.
Curr Infect Dis Rep. 2006 Jan;8(1):69-75.
Abstract

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter
AIDS cohort study.
Brown TT, Cole SR, Li X, et al
Arch Intern Med. 2005 May 23;165(10):1179-84
Abstract

Case-Control Study of Diabetes Mellitus in HIV-Infected Patients.
Yoon C, Gulick RM, Hoover DR, et al
J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1464-1469.
Abstract

Sustaining dietary changes for preventing obesity and diabetes: lessons learned from
the successes of other epidemic control programs.
Swinburn B.
Asia Pac J Clin Nutr 2002;11 Suppl 3:S598-606
Abstract

Syndrome of lipodystrophy, hyperlipidemia, insulin resistance, and diabetes in treated
patients with human immunodeficiency virus infection.
Graber AL.
Endocr Pract 2001 Nov-Dec;7(6):430-7
Abstract

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated
lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.
Carr A, Samaras K, Thorisdottir A, Kaufmann GR, et al.
Lancet 1999 Jun 19;353(9170):2093-9
Abstract

Conference Reports, Abstracts, and Posters

Predicting the short-term risk of diabetes in HIV-infected patients in the D:A:D cohort:
the D:A:D study group
Petoumenos K, Fontas E, Worm SW, et al
(Ninth International Congress on Drug Therapy in HIV Infection)
Abstract

Underutilization of Recommended Interventions for Prevention of Cardiovascular Disease in
HIV-infected Patients with Established Cardiovascular Disease or Diabetes
C Sabin, R Weber, E Fontas, et al
(14 CROI)
Abstract

Comparison of Diabetes Mellitus Prevalence and Risk Factors among HIV-infected ART-naïve
Individuals vs Individuals in the NHANES III Cohort
IBrar, J Shute, D Wentworth, et al
(13 CROI)
Abstract

Diabetes Mellitus in HIV-infected Persons: The Role of CD4 Counts
A Butt, D Kelley, K McGinnis, et al
(13 CROI)
Abstract

POSTER
Duration of Indinavir and D4T Therapy Is Associated With New-Onset Type 2
Diabetes Mellitus
H Crane, S Van Rompaey, M Kitatata
(11 CROI)
PDF Poster Abstract

Diabetes and Cognitive Functioning Among HIV Seropositive Patients. The Hawaii
Aging with HIV Cohort
V Valcour, C Shikuma, B Shiramizu, et al
(11 CROI))
Abstract

POSTER
Diabetes Mellitus in HIV-Infected Individuals
JS Currier, F Boyd, H Kawabata, et al.
(9 CROI)
PDF Poster Abstract

POSTER
Case-Control Study of Diabetes Mellitus in HIV-Infected Patients
C Yoon, R Gulick, D Hoover, et al.
(9 CROI)
PDF Poster Abstract

POSTER
The Effect of HAART and HCV Infection on the Development of Diabetes Mellitus
S Mehta, R Moore, D Thomas, et al.
(9 CROI)
PDF Poster Abstract

HIV Metabolic Disorders Main Page

Main New/Newsworthy

Home Page

Glucose Metabolic Alterations/Disorders